Major Health Organizations in China Install ZOLL Defibrillators

Over 250 M Series have been installed in both ambulances and hospitals in Beijing over the past 18 months to service the Summer Olympic Games and help improve the city's emergency service levels. In Shanghai, the largest city in China, the M Series has been selected to equip the city's newly-expanded ambulance service. To date, the Shanghai Medical Emergency Service Center has placed 145 M Series into service in the metropolitan area.

In addition, ZOLL was awarded a Beijing government public tender to install 191 AED Plus(R) units into Community Medical Service Centers in Beijing City. This project marks the first time that AEDs are being made available to local residents in China through health centers and clinics. This is an integral part of China's new healthcare system, which is designed to provide healthcare and first rescue response at the community level.

"China represents an important future market opportunity for ZOLL. Although modest in proportion to our consolidated results, over the past two years, our growth in China has exceeded 100 percent," said Richard A. Packer, Chairman and Chief Executive Officer of ZOLL. "We're especially pleased that major health agencies in China recognize the value, reliability and consistency of our product portfolio, and are using our defibrillators, AEDs and AutoPulse(R) to improve outcomes from sudden cardiac arrest, the globe's leading cause of unexpected death."

Chinese Market Continues to Expand for ZOLL

Installation of the M Series and the AED Plus follows an earlier announcement that several major hospitals and EMS services in China have installed ZOLL's AutoPulse(R) Non-invasive Cardiac Support Pump. Four AutoPulse units will be onsite with Shenyang EMS during the Olympic soccer games taking place in that city next month. Earlier in the year, ZOLL announced that 80 AED Plus units were being installed in newly-built Terminal 3 at Beijing International Airport, the gateway terminal for the 2008 Beijing Summer Olympics.

M Series--Compact, Lightweight Defibrillator for Easy Handling

The small, rugged M Series is an easy-to-use portable unit packed with power. With straightforward controls and optimal viewing features, it provides everything for cardiac resuscitation: defibrillation, external pacing and advanced monitoring capabilities. Its 12-lead ECG data transmission provides clinicians with information from the field to assess the patient's condition before arriving at the hospital for improved diagnosis and treatment of patients.

AED Plus--The Only Full-rescue AED

The AED Plus supports the entire chain of survival and guides rescuers through the life-saving process. It provides complete instruction on whether and when to administer a defibrillating shock and step-by-step CPR instructions using Real CPR Help(R). This real-time auditory feedback coaches rescuers to provide the proper rate and depth of chest compression to deliver the best manual CPR possible.

About Sudden Cardiac Arrest

SCA claims more than 1 million lives each year worldwide. It is the leading cause of unexpected death in the world and strikes without warning. Currently, only about 5 percent of victims survive; 95 percent will die from SCA. SCA is an abrupt disruption of the heart's function, which causes a lack of blood flow to vital organs.

About ZOLL Medical Corporation

ZOLL Medical Corporation is committed to developing technologies that help advance the practice of resuscitation. With products for pacing, defibrillation, circulation, ventilation, and fluid resuscitation, ZOLL provides a comprehensive set of technologies, including Real CPR Help and See-Thru CPR(R), that help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims. ZOLL also designs and markets software that automates the documentation and management of both clinical and non-clinical information.

ZOLL markets and sells its products in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia. 2008 marks the 25th anniversary of ZOLL's resuscitation product development. For more information, visit www.zoll.com.

Certain statements contained in this press release, including statements regarding the future business of the Company, and other statements contained herein regarding matters that are not historical facts, are "forward-looking" statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those factors discussed in the section entitled "Risk Factors" in the Company's Quarterly Report on Form 10-Q filed with the SEC on May 9, 2008. You should not place undue reliance on the forward-looking statements in this press release, and the Company disavows any obligation to update or supplement those statements in the event of any changes in the facts, circumstances, or expectations that underlie those statements.

Copyright (C) 2008 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. ZOLL, AED Plus, AutoPulse, M Series, Real CPR Help, and See-Thru CPR are registered trademarks of ZOLL Medical Corporation. All product names are the property of their respective owners.

SOURCE: ZOLL Medical Corporation

Investor Contact: ZOLL Medical Corporation A. Ernest Whiton, +1 978-421-9655 Chief Financial Officer or Media Contacts: ZOLL Medical Corporation Diane Egan, +1 978-421-9637 degan@zoll.com or Publicis Consultants / PR Kim Angelastro, +1 212-527-8866 kim.angelastro@publicis-pr.com